You are here:

Home
NICE Guidance
Conditions and diseases
Cancer
Prostate cancer

Enzalutamide for hormone-relapsed non-metastatic prostate cancer

Technology appraisal guidance
Reference number: TA580
Published: 15 May 2019

Guidance
Tools and resources
Information for the public
Evidence
History

Tools and resources

Tools to help you put the guidance into practice.

Guidance into practice

About the Into practice guide
Practical steps to improving the quality of care and services using NICE guidance